- Home
- XTNT vs CREX Comparison
XTNT vs CREX Comparison
Compare XTNT & CREX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XTNT
- CREX
- Stock Information
- Founded
- XTNT N/A
- CREX N/A
- Country
- XTNT United States
- CREX United States
- Employees
- XTNT N/A
- CREX N/A
- Industry
- XTNT Biotechnology: Biological Products (No Diagnostic Substances)
- CREX EDP Services
- Sector
- XTNT Health Care
- CREX Technology
- Exchange
- XTNT Nasdaq
- CREX Nasdaq
- Market Cap
- XTNT 55.6M
- CREX 44.8M
- IPO Year
- XTNT N/A
- CREX N/A
- Fundamental
- Price
- XTNT $0.38
- CREX $2.95
- Analyst Decision
- XTNT Strong Buy
- CREX Strong Buy
- Analyst Count
- XTNT 1
- CREX 2
- Target Price
- XTNT $3.00
- CREX $8.00
- AVG Volume (30 Days)
- XTNT 224.7K
- CREX 65.6K
- Earning Date
- XTNT 11-12-2024
- CREX 11-13-2024
- Dividend Yield
- XTNT N/A
- CREX N/A
- EPS Growth
- XTNT N/A
- CREX N/A
- EPS
- XTNT N/A
- CREX 0.07
- Revenue
- XTNT $113,862,000.00
- CREX $54,300,000.00
- Revenue This Year
- XTNT $31.82
- CREX $22.92
- Revenue Next Year
- XTNT $13.64
- CREX $18.39
- P/E Ratio
- XTNT N/A
- CREX $41.26
- Revenue Growth
- XTNT 45.11
- CREX 31.80
- 52 Week Low
- XTNT $0.33
- CREX $2.09
- 52 Week High
- XTNT $1.31
- CREX $5.20
- Technical
- Relative Strength Index (RSI)
- XTNT 35.87
- CREX 42.78
- Support Level
- XTNT $0.35
- CREX $2.76
- Resistance Level
- XTNT $0.39
- CREX $3.10
- Average True Range (ATR)
- XTNT 0.02
- CREX 0.23
- MACD
- XTNT 0.00
- CREX 0.04
- Stochastic Oscillator
- XTNT 56.22
- CREX 66.13
About XTNT Xtant Medical Holdings Inc.
Xtant Medical Holdings Inc is a medical technology company focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal implant systems to facilitate spinal fusion in complex spine, deformity and degenerative procedures. Its products are used by orthopedic spine surgeons and neurosurgeons to treat a variety of spinal disorders in the cervical, thoracolumbar, and interbody spine. The company's biomaterial products include OsteoSponge, OsteoSponge SC, OsteoSelect Plus DBM putty, OsteoWrap, and the line of 3Demin products, as well as other allografts. It generates a majority of its revenue from the US.
About CREX Creative Realities Inc.
Creative Realities Inc, along with its subsidiaries, is engaged in providing digital marketing technology & solutions to global retail companies, luxury and other individual retail brands, advertising networks, outdoor clients, enterprises, and other organizations. The Company operates in one reportable segment, marketing technology solutions. The company provides solutions related to digital merchandising systems, omnichannel customer engagement systems, interactive digital shopping assistants, advisors and kiosks, and high-end audio-visual networks along with marketing technologies such as mobile, social media, point-of-sale transactions, beaconing, and web-based media.